Stockreport

BiondVax to Present at Influenza 2018 Oxford Conference

BiondVax Pharmaceuticals Ltd. - American Depositary Shares  (BVXV) 
US:NASDAQ Investor Relations: biondvax.com/investors
PDF JERUSALEM, Sept. 4, 2018 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), developer of the M-001 universal influenza vaccine candidate, reported today it wi [Read more]